[1] 逄琳,陈新,王艳.F-PSA/T-PSA联合MRI在前列腺癌诊断中的应用价值[J].实用癌症杂志,2016,31(4):635-637.
[2] 马向征,王世威,许茂盛,等.DCE-MRI联合DWI定量分析在前列腺癌诊断中的应用价值[J].浙江医学,2017,39(1):7-11.
[3] GAO P,SHI C,ZHAO L,et al.Differential diagnosis of prostate cancer and noncancerous tissue in the peripheral zone and central gland using the quantitative parameters of DCE-MRI:A meta-analysis[J].Medicine,2016,95(52):5217-5225.
[4] 王海宝,刘灿,贾媛,等.DWI及动态增强MRI定量检测在前列腺癌诊断中的应用[J].蚌埠医学院学报,2016,41(9):1234-1236.
[5] 景国东,金爱国,吴骋,等.前列腺癌、增生结节及外周带非癌组织在3.0T MR动态增强灌注成像中的强化表现[J].放射学实践,2016,31(8):756-759.
[6] 冷晓明,韩晓蕊,徐嬿,等.IVIM-DWI和定量DCE-MRI鉴别前列腺癌和前列腺增生——灌注系数的相关性研究[J].影像诊断与介入放射学,2016,25(5):390-395.
[7] CAI W,LI F,WANG J,et al.A comparison of arterial spin labeling perfusion MRI and DCE-MRI in human prostate cancer[J].NMRBiomed,2014,27(7):817-825.
[8] 陈杰,任永芳,曲源.磁共振LAVA动态增强半定量分析对前列腺癌的诊断价值[J].中国CT和MRI杂志,2016,14(1):102-105.
[9] 王君鑫,赵文露,杨毅,等.动态增强MRI三维定量参数直方图诊断前列腺癌的价值[J].中华放射学杂志,2016,50(8):609-614.
[10] SINGGANANMALLI A,RUSU M,SPARKS R E,et al.Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer[J].JMagn Reson Imaging,2016,43(1):149-158.
[11] 王君鑫,赵文露,杨毅,等.动态增强MRI三维定量参数直方图诊断前列腺癌的价值[J].中华放射学杂志,2016,50(8):609-614.
[12] 赵莲萍,高鹏,张文文,等.3.0T多参数MRI对前列腺良恶性病变的诊断价值[J].中国医学影像学杂志,2016,24(10):778-782.
[13] FENNESSY F M,FEDOROV A,PENZKOFER T,et al.Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T:comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation[J].Magn Reson Imaging,2015,33(7):886-894.
[14] FEDOROV A,FLUCKIGER J,AYERS G D,et al.A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer:a step towards practical implementation.[J].Magn Reson Imaging,2014,32(4):321-329. |